LeadIQ logo
Learn more at LeadIQ.com

Insights

Gene Therapy Research The Gene Therapy Program at the University of Pennsylvania, led by Dr. James Wilson, focuses on pioneering gene transfer vectors for treating acquired and inherited diseases, presenting an opportunity for collaboration with biotech companies in need of cutting-edge genetic therapeutics.

Tech Stack Utilization With a tech stack including React, Apache, and more, the University of Pennsylvania's Gene Therapy Program demonstrates a focus on innovative technology solutions. Tech companies offering complementary services or tools can explore partnership opportunities to enhance research and development processes.

Market Recognition The University of Pennsylvania is consistently recognized for its academic excellence and research achievements, making it an attractive partner for companies looking to align with top-ranking institutions for collaborative research projects or clinical trials.

Financial Stability With revenue between $10M-$50M, the Gene Therapy Program shows financial health and potential for investment or funding collaborations. Financial institutions or investors seeking opportunities in the biotechnology sector can explore partnerships or funding arrangements.

Employee Talent Pool As an institution known for nurturing top talent, the Gene Therapy Program at the University of Pennsylvania offers access to a skilled workforce for companies seeking research or project collaborations, presenting opportunities for talent acquisition or knowledge exchange.

Similar companies to Gene Therapy Program | University of Pennsylvania

Gene Therapy Program | University of Pennsylvania Tech Stack

Gene Therapy Program | University of Pennsylvania uses 8 technology products and services including Avid Pro Tools, React, Slick, and more. Explore Gene Therapy Program | University of Pennsylvania's tech stack below.

  • Avid Pro Tools
    Audio, Video, Graphics
  • React
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Office 365
    Office Suites
  • JSON
    Programming Languages
  • Apache
    Web Servers
  • Facebook
    Widgets

Media & News

Gene Therapy Program | University of Pennsylvania's Email Address Formats

Gene Therapy Program | University of Pennsylvania uses at least 1 format(s):
Gene Therapy Program | University of Pennsylvania Email FormatsExamplePercentage
FLast@upenn.eduJDoe@upenn.edu
84%
FirstL@upenn.eduJohnD@upenn.edu
6%
Last@upenn.eduDoe@upenn.edu
5%
LastF@upenn.eduDoeJ@upenn.edu
5%

Frequently Asked Questions

Where is Gene Therapy Program | University of Pennsylvania's headquarters located?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania's main headquarters is located at 125 S 31st St Philadelphia, Pennsylvania US. The company has employees across 2 continents, including North AmericaEurope.

What is Gene Therapy Program | University of Pennsylvania's phone number?

Minus sign iconPlus sign icon
You can contact Gene Therapy Program | University of Pennsylvania's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Gene Therapy Program | University of Pennsylvania's stock symbol?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania is a publicly traded company; the company's stock symbol is N/A.

What is Gene Therapy Program | University of Pennsylvania's official website and social media links?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania's official website is upenn.edu and has social profiles on LinkedIn.

How much revenue does Gene Therapy Program | University of Pennsylvania generate?

Minus sign iconPlus sign icon
As of October 2024, Gene Therapy Program | University of Pennsylvania's annual revenue reached $35M.

What is Gene Therapy Program | University of Pennsylvania's SIC code NAICS code?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gene Therapy Program | University of Pennsylvania have currently?

Minus sign iconPlus sign icon
As of October 2024, Gene Therapy Program | University of Pennsylvania has approximately 201 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer (cmc Gene Therapy): S. Z. S.Chief Medical Officer: F. C.Executive Director, Orphan Disease Center And Chief Administrative Officer, Gene Therapy Program: M. M.. Explore Gene Therapy Program | University of Pennsylvania's employee directory with LeadIQ.

What industry does Gene Therapy Program | University of Pennsylvania belong to?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania operates in the Biotechnology Research industry.

What technology does Gene Therapy Program | University of Pennsylvania use?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania's tech stack includes Avid Pro ToolsReactSlickjQueryOffice 365JSONApacheFacebook.

What is Gene Therapy Program | University of Pennsylvania's email format?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania's email format typically follows the pattern of . Find more Gene Therapy Program | University of Pennsylvania email formats with LeadIQ.

When was Gene Therapy Program | University of Pennsylvania founded?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania was founded in 1993.
Gene Therapy Program | University of Pennsylvania

Gene Therapy Program | University of Pennsylvania

Biotechnology ResearchPennsylvania, United States201-500 Employees

Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. 

Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy.

After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published more than 550 papers and is named on more than 110 patents.

Today, the goals of the Gene Therapy Program are to develop and commercialize transformative, genetic-based therapeutics. These goals are driven by the unmet needs of patients with inherited genetic diseases.

The Gene Therapy Program currently employs more than 350+ full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.

Section iconCompany Overview

Headquarters
125 S 31st St Philadelphia, Pennsylvania US
Phone number
Website
upenn.edu
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
N/A
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1993
Employees
201-500

Section iconFunding & Financials

  • $10M$50M

    Gene Therapy Program | University of Pennsylvania's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Gene Therapy Program | University of Pennsylvania's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.